HLA ASSOCIATION OF ANTI-RO60 AND ANTI-RO52 ANTIBODIES IN SJOGRENS-SYNDROME

被引:20
作者
RICCHIUTI, V
ISENBERG, D
MULLER, S
机构
[1] INST BIOL MOLEC & CELLULAIRE, DEPT IMMUNOCHEM, CNRS, UPR 9021, F-67084 STRASBOURG, FRANCE
[2] UCL, DEPT MED, BLOOMSBURY RHEUMATOL UNIT, LONDON, ENGLAND
关键词
D O I
10.1006/jaut.1994.1045
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The possible pathological role of antibody subsets specific for different regions of 60-KD and 52-KD Ro/SSA proteins (Ro60 and Ro52) and La protein is unclear. Previously, we have shown that in patients with Sjogren's syndrome, the fine specificity of Ro60 and Ro52 antibodies, as characterized with synthetic peptides, varied considerably according to the origin of sera. We therefore looked for possible associations of HLA class I and class II alleles with Ro and La IgG antibodies in patients with primary Sjogren's syndrome (n=24) and secondary Sjogren's syndrome associated with systemic lupus erythematosus (n=25). Ro60 and Ro52 antibodies were tested by ELISA with the complete parent proteins and with 10 to 24 residue-long peptides of these proteins. Anti-Ro60 antibodies were more frequent in DR3-positive patients and in DQ1-negative patients whereas the presence of Ro52 and La IgG antibodies was significantly increased in patients with A1/B8/DR3 haplotype. Certain HLA associations observed with antibodies reacting with the whole Ro52 protein were not found with antibodies reacting with certain Ro60 and Ro52 peptides and, reciprocally, certain anti-peptide antibodies were linked to particular haplotypes whereas antibodies to the respective parent proteins were not linked to these haplotypes. Thus the production of antibody subsets reacting with different parts or presentations of Ro proteins is, at least in part, influenced immunologically by different HLA haplotypes, and this predisposition may play a role in the pathological development of the disease.
引用
收藏
页码:611 / 621
页数:11
相关论文
共 25 条
[1]   GENETIC-STUDIES IN SJOGRENS SYNDROME AND SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
ARNETT, FC ;
BIAS, WB ;
REVEILLE, JD .
JOURNAL OF AUTOIMMUNITY, 1989, 2 (04) :403-413
[2]  
BARAKAT S, 1992, CLIN EXP IMMUNOL, V89, P38
[3]  
BOZIC B, 1993, CLIN EXP IMMUNOL, V94, P227
[4]   FAMILY STUDY OF THE MAJOR HISTOCOMPATIBILITY COMPLEX IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS - IMPORTANCE OF NULL ALLELES OF C4A AND C4B IN DETERMINING DISEASE SUSCEPTIBILITY [J].
FIELDER, AHL ;
WALPORT, MJ ;
BATCHELOR, JR ;
RYNES, RI ;
BLACK, CM ;
DODI, IA ;
HUGHES, GRV .
BMJ-BRITISH MEDICAL JOURNAL, 1983, 286 (6363) :425-428
[5]  
FOX RI, 1991, ARTHRITIS RHEUM, V34, P1617
[6]   HLA-DQ GENE COMPLEMENTATION AND OTHER HISTOCOMPATIBILITY RELATIONSHIPS IN MAN WITH THE ANTI-RO/SSA AUTOANTIBODY RESPONSE OF SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
FUJISAKU, A ;
FRANK, MB ;
NEAS, B ;
REICHLIN, M ;
HARLEY, JB .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (02) :606-611
[7]   GENE INTERACTION AT HLA-DQ ENHANCES AUTOANTIBODY PRODUCTION IN PRIMARY SJOGRENS-SYNDROME [J].
HARLEY, JB ;
REICHLIN, M ;
ARNETT, FC ;
ALEXANDER, EL ;
BIAS, WB ;
PROVOST, TT .
SCIENCE, 1986, 232 (4754) :1145-1147
[8]  
HARLEY JB, 1989, ARTHRITIS RHEUM, V32, P826
[9]  
HARLEY JB, 1991, SYSTEMIC AUTOIMMUNIT, P247
[10]   THE GENETIC-BASIS OF RO AND LA ANTIBODY-FORMATION IN SYSTEMIC LUPUS-ERYTHEMATOSUS - RESULTS OF A MULTICENTER STUDY [J].
HARTUNG, K ;
EHRFELD, H ;
LAKOMEK, HJ ;
COLDEWEY, R ;
LANG, B ;
KRAPF, F ;
MULLER, R ;
SCHENDEL, D ;
DEICHER, H ;
SEELIG, HP ;
ALBERT, E ;
BAUR, M ;
CORVETTA, A ;
FREY, J ;
KALDEN, JR ;
DELANGE, GG ;
PETER, HH ;
PIRNER, K ;
ROTHER, R ;
SCHNEIDER, P ;
SEUCHTER, S ;
SPATH, P ;
SPECKER, C ;
STANGEL, W ;
STANNATKIESSLING, S .
RHEUMATOLOGY INTERNATIONAL, 1992, 11 (06) :243-249